Hyon E. Choy

Chonnam National University — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

44h-index7.2kcitations153works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(44), Nanoplatforms for cancer theranostics(24), Vibrio bacteria research studies(24), Bacterial Genetics and Biotechnology(23), Virus-based gene therapy research(21)

Publications153 total

Inverse agonist of ERRγ controls influenza A virus and SARS-CoV-2 infections by targeting SREBP-1c-mediated fatty acid biosynthesis
2025Open Access
Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella
Oncogene·2025
Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum
Oncogene·2024· 5 cited
Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum
2024Open Access
Mucosal TLR5 activation controls healthspan and longevity
Nature Communications·2024· 19 citedOpen Access
Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum
Molecular Therapy — Oncolytics·2023· 6 citedOpen Access
Analysis of random mutations in Salmonella Gallinarum dihydropteroate synthase conferring sulfonamide resistance
Archives of Microbiology·2023· 4 cited
Analysis of antibiotic resistance gene cassettes in a newly identified Salmonella enterica serovar Gallinarum strain in Korea
Mobile DNA·2023· 7 citedOpen Access
Data from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure 3 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure 2 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure 1 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure Legends 1-3 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure 1 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Data from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure Legends 1-3 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure 2 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Supplementary Figure 3 from Genetically Engineered <i>Salmonella typhimurium</i> as an Imageable Therapeutic Probe for Cancer
2023Open Access
Constitutive Expression of a Cytotoxic Anticancer Protein in Tumor-Colonizing Bacteria
Cancers·2023· 6 citedOpen Access
Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus
Signal Transduction and Targeted Therapy·2022· 42 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Joon Haeng Rhee(20), Jung‐Joon Min(16), Yeongjin Hong(15), Young Ran Kim(12), Shee Eun Lee(10), Vu H. Nguyen(9), Jae‐Ho Jeong(8), Soo Young Kim(7), Sun Sik Chung(6), Seung‐Hwan Park(5), Hee‐Seung Bom(5), Hyung-Seok Kim(5), Jin Zheng(4), Shengnan Jiang(4), Choon Mee Kim(4), Minsang Shin(4), Mi‐Ryoung Song(4), Tae‐Hoon Lee(4), Daejin Lim(4), Myung‐Geun Shin(3)